As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.
So let's look at two noteworthy recent insider buys.
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.
So let's look at two noteworthy recent insider buys.
On Wednesday, Bright Health Group's, Manuel Kadre, made a $959,000 purchase of BHG, buying 100,000 shares at a cost of $9.59 each.
Kadre was up about 6.5% on the buy at the high point of today's trading session, with BHG trading as high as $10.21 in trading on Monday.
Bright Health Group is trading up about 4.5% on the day Monday.
Before this latest buy, Kadre bought BHG at 3 other times during the past twelve months, for a total cost of $692,025 at an average of $8.65 per share.
And at Immunome, there was insider buying on Friday, by Director Michael Rapp who bought 45,950 shares for a cost of $18.07 each, for a trade totaling $830,449.
Before this latest buy, Rapp bought IMNM on 3 other occasions during the past twelve months, for a total cost of $2.97M at an average of $15.59 per share.
Immunome is trading up about 5.9% on the day Monday.
So far Rapp is in the green, up about 10.4% on their purchase based on today's trading high of $19.95.
Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider..
As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to..
